Penalty Amount
$103,420
The FTC distributed refunds to consumers who purchased deceptively marketed treatment plans from Golden Sunrise Nutraceutical. The company and its medical director were barred from making unsupported health claims about curing COVID-19, cancer, and Parkinson's disease after a court order in September 2025. Over $40,700 was sent to 578 consumers, with additional claims possible until May 2026.
Defendants were ordered to pay $103,420 in monetary penalties, barred from making unsupported health claims in the future, and required to provide refunds to affected consumers totaling over $40,700.
In-house legal teams should review all customer-facing agreements (including sales contracts, terms of service, and marketing partnership agreements) and vendor agreements where marketing materials or product descriptions are provided. Focus on representations and warranties clauses regarding the accuracy of marketing claims, compliance with FTC Act Section 5, and product efficacy statements. Specific clauses to scrutinize include those governing marketing material approval processes, indemnification for regulatory actions, and termination rights for breach of compliance obligations. Changes may be needed to require pre-approval of any health-related claims, mandate documented scientific evidence for efficacy statements, and include explicit prohibitions against claiming products can cure specific diseases like COVID-19, cancer, or Parkinson's without FDA review and approval.
Entity
Golden Sunrise Nutraceutical, Inc.
Also known as: Golden Sunrise Nutraceutical
Industry
HealthcareOfficial Press Release
https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-sends-checks-consumers-who-bought-certain-products-golden-sunrise-nutraceutical-between-2017
promoter 23000 covid 19 treatment plan barred making bogus h
https://www.ftc.gov/news-events/news/press-releases/2021/06/promoter-23000-covid-19-treatment-plan-barred-making-bogus-health-claims
GoldenSunrise Order
https://www.ftc.gov/system/files/ftc_gov/pdf/GoldenSunrise-Order.pdf
ftc announces refund claims process consumers who bought dec
https://www.ftc.gov/news-events/news/press-releases/2025/01/ftc-announces-refund-claims-process-consumers-who-bought-deceptively-marketed-golden-sunrise
GoldenSunrise
https://www.ftc.gov/GoldenSunrise
Federal Trade Commission Enforcement Page
https://www.ftc.gov/enforcement
"Golden Sunrise Nutraceutical, Inc."
"ordered to pay $103,420"
"deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19, and used false or unproven claims that other treatment plans could cure cancer and Parkinson’s disease"
"578 affected consumers"
"In September 2025"
"barred them from making unsupported health claims in the future"
The FTC filed a complaint alleging that GovAssist LLC, Entry LLC, and Scott Zuckerman used deceptive paid search ads, misleading service and pricing claims, and fake reviews to deceive consumers seeking passport services. The complaint alleges violations of the FTC Act, the Impersonation Rule, and the Gramm-Leach-Bliley Act; the case will be decided by the court, and no penalty or remedy is reported as imposed.
The FTC issued its annual report to Congress describing fraud trends affecting older adults and the agency’s enforcement, education, and outreach efforts. The report is not a specific privacy enforcement action and announces no penalty or remedy.
The FTC referred a complaint against REPS & Company Inc. and company executives, alleging they bypassed ticket-issuer security controls and purchasing limits to acquire millions of tickets for resale. The complaint was filed by the Department of Justice, and the case will be decided by the court; the press release does not report a penalty or other remedy imposed.
$106.8M
A federal court entered a $106.8 million default judgment against corporate defendants in an alleged debt-relief scheme that impersonated banks and government entities and targeted seniors and veterans. The judgment permanently bans the defendants from the debt-relief industry and imposes additional prohibitions, including on impersonation, telemarketing, and misrepresentations.
The FTC sued Digital Forensics Corporation LLC and affiliated defendants, alleging they misled sextortion victims with promises of investigative and monitoring services that often were not provided, and used fake positive reviews. A federal court granted the FTC’s request to temporarily halt the defendants’ activities; the complaint remains for the court to decide.
The FTC alleged that Greenway Auto Group advertised vehicle prices thousands of dollars below the amounts consumers actually paid and used mailers falsely suggesting recipients had won cash prizes. Greenway agreed to an order requiring transparent pricing and prohibiting deceptive prize mailers and other misrepresentations; the press release does not state a monetary penalty.